News

An international team, including scientists from The University of Queensland and the Garvan Institute of Medical Research, has described the mutational processes that drive tumour development in 30 of the most common cancer types.

Cancer, mental disorders and neurological diseases could soon be detected earlier with cutting edge equipment available at the new $22 million Herston Imaging Research Facility (HIRF).

Researchers from The University of Queensland and The University of Newcastle are conducting a national survey to combat unintended pregnancy, which accounts for half of all pregnancies in Australia.

People with Parkinson's disease who receive Deep Brain Stimulation (DBS) therapy in the early stages of the condition will benefit from a significant increase in quality of life, a revolutionary study from The New England Journal of Medicine has found.

The University of Queensland Centre for Clinical Research has received almost $60,000 in funding from the Diabetes Australia Research Trust for innovative research to improve the detection and treatment of gestational diabetes in pregnant women.

The University of Queensland researchers have successfully restored wound healing in a model of diabetes paving the way for new treatments for chronic wounds.

The University of Queensland's Centre for Clinical Research has received $2 million in funding from the Australian Cancer Research Foundation (ACRF) for state-of-the-art imaging equipment that will improve the diagnosis and treatment of cancer in patients.

A recent study from The University of Queensland's Centre for Clinical Research (UQCCR) delivers some of the first empirical data about public attitudes towards performance enhancing drugs.

The UQ Centre for Clinical Research is tackling Fetal Alcohol Spectrum Disorder (FASD) by educating the public about the dangers of drinking during pregnancy.

A new study from The University of Queensland shows monitoring the brain of stroke patients using Quantitative EEG (QEEG) studies could inform treatments and therefore, minimising brain damage of stroke victims.

Australian life sciences researchers will translate their discoveries into commercial products faster thanks to a newly established Queensland Node of the Therapeutic Innovation Australia (TIA – Qld Node).

Researchers at UQ's Australian Institute for Bioengineering and Nanotechnology (AIBN) are a step closer to understanding and combating the degenerative brain disease ataxia-telangiectasia.

The University of Queensland School of Dentistry’s Oral Oncology Research Program has secured major grant funding to support new research.

A University of Queensland researcher has discovered nine new genes that drive the development of breast cancer, taking the tally of all genes associated with breast cancer development to 40.

Research is urgently needed into the cumulative effects of head trauma over long periods, according to articles released online today by the Medical Journal of Australia.

A new multi-million dollar Asia-Pacific Centre for Neuromodulation (APCN) in Brisbane is poised to become a world leader in research to revolutionise the diagnosis and treatment of neurological disease.

University of Queensland scientists have developed a world-first method for producing adult stem cells that will substantially impact patients who have a range of serious diseases.

A new Australian drug study published today in The Lancet has found that cannabis is the most widely used illicit drug globally, while opioid use is a major cause of death.

On November 30, Associate Professor Kiarash Khosrotehrani from the UQ Centre for Clinical Research, received an achievement award at the National Health and Medical Research Council's (NHMRC) 75th Anniversary Symposium.